or
forgot password

    • cancer clinical trials in oregon

    • Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Leukemia
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Legacy Mount Hood Medical Center

    Trial Locations
    Legacy Mount Hood Medical Center
    Providence Milwaukie Hospital
    CCOP - Columbia River Oncology Program
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Legacy Meridian Park Hospital
    Lymphoma
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Bay Area Hospital

    Trial Locations
    Bay Area Hospital
    Kaiser Permanente
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Oregon Health and Science University
    Portland, Oregon 97201
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    St. Charles Medical Center - Bend

    Trial Locations
    St. Charles Medical Center - Bend
    Clackamas Radiation Oncology Center
    Bay Area Hospital
    Three Rivers Community Hospital
    Dubs Cancer Center at Rogue Valley Medical Center
    Providence Cancer Center at PMCC
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Three Rivers Community Hospital

    Trial Locations
    Three Rivers Community Hospital
    Legacy Mount Hood Medical Center
    Dubs Cancer Center at Rogue Valley Medical Center
    Providence Cancer Center at PMCC
    Providence Milwaukie Hospital
    CCOP - Columbia River Oncology Program
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Northwest Cancer Specialists at Rose Quarter Cancer Center
    Salem Hospital Regional Cancer Care Services
    Legacy Meridian Park Hospital
    Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    Oregon Health & Science University
    Portland, Oregon 97201
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Salem Hospital Regional Cancer Care Services
    Salem, Oregon 97309-5014
    Breast Cancer, Metastatic Cancer
    Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
    Oregon Health Sciences University
    Portland, Oregon
    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, NK Cell Lymphoblastic Leukemia
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Bend Memorial Clinic
    Bend, Oregon 97701
    Mycoses, Candidiasis, Invasive, Candidemia
    Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
    Oregon Health & Science University
    Portland, Oregon 97201
    Lymphangioleiomyomatosis
    Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Providence Cancer Center at Providence Portland Medical Center

    Trial Locations
    Providence Cancer Center at Providence Portland Medical Center
    OHSU Knight Cancer Institute
    Salem Hospital
    Kidney Cancer
    A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Metastatic Breast Cancer, Advanced Breast Cancer, Advanced Gastric Cancer, Advanced/Metastatic Non-small Cell Lung Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Metastatic Castration-resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non Small Cell Lung Cancer, Pancreatic Islet Cell Carcinoma, Pancreatic Neuroendocrine Tumor, Thyroid Cancer